首页>
外国专利>
USAGE OF NAPHTHOPIZIL FOR TREATMENT OF DYSURIA IN BENIGN PROSTATIC HYPERPLASIA
USAGE OF NAPHTHOPIZIL FOR TREATMENT OF DYSURIA IN BENIGN PROSTATIC HYPERPLASIA
展开▼
机译:萘哌唑在治疗前列腺增生症中的营养不良中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
PURPOSE: To prepare a therapeutic agent for dysuria in benign prostate hypertrophy comprising naftopidil or its salt as an active ingredient. CONSTITUTION: This therapeutic agent for dysuria comprises 1-(2- methoxyphenyl)-4-[3-(naphth-l-yl-oxy)-2-hydroxy-propyll-piperazine (naftopidil), having antihypertensive action, known to control anaphylactic reaction caused by dextran in a rat and represented by the formula as an active ingredient. The compound is especially orally applied and the daily dose thereof is 10-100mg and administered in a dose of 10-50mg at a time daily once or twice.
展开▼